1. Home
  2. ICCC vs HGBL Comparison

ICCC vs HGBL Comparison

Compare ICCC & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • HGBL
  • Stock Information
  • Founded
  • ICCC 1982
  • HGBL 1937
  • Country
  • ICCC United States
  • HGBL United States
  • Employees
  • ICCC N/A
  • HGBL N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • HGBL Business Services
  • Sector
  • ICCC Health Care
  • HGBL Consumer Discretionary
  • Exchange
  • ICCC Nasdaq
  • HGBL Nasdaq
  • Market Cap
  • ICCC 60.1M
  • HGBL 66.7M
  • IPO Year
  • ICCC 1987
  • HGBL N/A
  • Fundamental
  • Price
  • ICCC $5.90
  • HGBL $1.86
  • Analyst Decision
  • ICCC
  • HGBL Strong Buy
  • Analyst Count
  • ICCC 0
  • HGBL 1
  • Target Price
  • ICCC N/A
  • HGBL $4.00
  • AVG Volume (30 Days)
  • ICCC 12.6K
  • HGBL 40.6K
  • Earning Date
  • ICCC 08-14-2025
  • HGBL 08-07-2025
  • Dividend Yield
  • ICCC N/A
  • HGBL N/A
  • EPS Growth
  • ICCC N/A
  • HGBL N/A
  • EPS
  • ICCC 0.20
  • HGBL 0.10
  • Revenue
  • ICCC $28,274,756.00
  • HGBL $48,940,000.00
  • Revenue This Year
  • ICCC N/A
  • HGBL $12.65
  • Revenue Next Year
  • ICCC N/A
  • HGBL $5.68
  • P/E Ratio
  • ICCC $30.45
  • HGBL $18.87
  • Revenue Growth
  • ICCC 21.75
  • HGBL N/A
  • 52 Week Low
  • ICCC $3.34
  • HGBL $1.52
  • 52 Week High
  • ICCC $7.60
  • HGBL $2.39
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 38.90
  • HGBL 34.60
  • Support Level
  • ICCC $5.92
  • HGBL $1.86
  • Resistance Level
  • ICCC $6.90
  • HGBL $2.20
  • Average True Range (ATR)
  • ICCC 0.36
  • HGBL 0.09
  • MACD
  • ICCC -0.05
  • HGBL -0.02
  • Stochastic Oscillator
  • ICCC 0.00
  • HGBL 16.67

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

Share on Social Networks: